Join the End Brain Cancer Initiative for GBM Awareness Day to support glioblastoma patients with specialized 1:1 navigation and access to clinical trials.
Join the End Brain Cancer Initiative for GBM Awareness Day to support glioblastoma patients with specialized 1:1 navigation and access to clinical trials.
Learn how Patrick "Paddy" O'Donnell's legacy fuels the future of AI and personalized medicine in healthcare on Glioblastoma (GBM) Awareness Day.
Discover how Patrick "Paddy" O'Donnell's journey inspires the future of AI and personalized treatments for glioblastoma brain cancer. Learn more at EBCI.
ROADS Trial Phase 3 results show tile-based radiation significantly improves overall survival & tumor control for newly diagnosed brain metastases.
Imaging Biometrics reports Phase 1 results for oral Gallium Maltolate (GaM) in recurrent glioblastoma (GBM), showing high tolerance & extended survival.
Other patients can benefit from your experience wearing the Optune Gio® device. We are seeking patients to share their story & their tips for using the device.
Other patients can benefit from your experience wearing the Optune Gio® device. We are seeking patients to share their story and best tips for using the device.
A phase 2 Immune12 trial is recruiting glioblastoma patients in Australia, with pre-qualification through EBCI. Immune12 is a marine biologic therapeutic.
Innovative diagnostic tests using a sample of cerebrospinal fluid that help clinicians detect and manage brain and spinal cord tumors.
Free 2026 GBM/rGBM webinar for patients, caregivers, and providers on treatment options, clinical trials, devices, and support.
Free GBM/rGBM webinar for patients and caregivers featuring treatment options, clinical trials, devices, and expert guidance.
Registration is open for the free Know All Your GBM/rGBM Treatment Options webinar, with expert insights on treatments, trials, and diagnostics.
